Document 0102 DOCN M9460102 TI Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4+ and CD8+ cells. DT 9408 AU Kinscherf R; Fischbach T; Mihm S; Roth S; Hohenhaus-Sievert E; Weiss C; Edler L; Bartsch P; Droge W; Department of Immunochemistry, Deutsches Krebsforschungszentrum,; Heidelberg, Germany. SO FASEB J. 1994 Apr 1;8(6):448-51. Unique Identifier : AIDSLINE MED/94222269 AB HIV-infected individuals and SIV-infected rhesus macaques have, on the average, decreased plasma cysteine and cystine concentrations and decreased intracellular glutathione levels. We show that the cysteine supply and the intracellular glutathione levels have a strong influence on the T cell system. A study of healthy human subjects revealed that persons with intracellular glutathione levels of 20-30 nmol/mg protein had significantly higher numbers of CD4+ T cells than persons with either lower or higher glutathione levels. Persons who moved during a 4-week observation period from the optimal to the suboptimal range (10-20 nmol/mg) experienced, on the average, a 30% decrease in CD4+ T cell numbers. This decrease was prevented by treatment with N-acetyl-cysteine (NAC). NAC caused this relative increase of CD4+ T cell numbers in spite of decreasing glutathione levels and not by increasing the glutathione level. Our studies suggest that the immune system may be exquisitely sensitive not only against a cysteine and glutathione deficiency but also against an excess of cysteine. DE Acetylcysteine/ADMINISTRATION & DOSAGE/*PHARMACOLOGY Administration, Oral Adult Antigens, CD8/*ANALYSIS Double-Blind Method Glutathione/*ANALYSIS Human Leukocyte Count/DRUG EFFECTS Male Middle Age T-Lymphocytes/*DRUG EFFECTS T4 Lymphocytes/*DRUG EFFECTS CLINICAL TRIAL JOURNAL ARTICLE RANDOMIZED CONTROLLED TRIAL SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).